Financhill
Back

ACADIA Pharmaceuticals Quote, Financials, Valuation and Earnings

Wall Street Caliber A.I. for the "Little Guy"

Get the full story here
Buy
56

ACAD
ACADIA Pharmaceuticals

Last Price:
20.82
Seasonality Move:
2.12%

7 Day Trial

ALL ACCESS PASS

$ 7

This new A.I. tech is a retirement game changer

Click Here

ACADIA Pharmaceuticals Price Quote

$20.82
+0.00 (+-3.3%)
(Updated: September 30, 2023 at 5:38 AM ET)

ACADIA Pharmaceuticals Key Stats

Buy
56
ACADIA Pharmaceuticals (ACAD) is a Buy

Day range:
$20.54 - $21.64
52-week range:
$13.73 - $33.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.15
P/B ratio:
8.61%

Volume:
2.5M
Avg. volume:
1.7M
1-year change:
28.97%
Market cap:
$3.4B
Revenue:
$517.2M
EPS:
$-0.69

How Much Does ACADIA Pharmaceuticals Make?

Is ACADIA Pharmaceuticals Growing As A Company?

ACADIA Pharmaceuticals Stock Price Performance

What Is ACADIA Pharmaceuticals 52-Week High & Low?

ACADIA Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ACADIA Pharmaceuticals?

Is ACADIA Pharmaceuticals Cash Flow Positive?

  • What Is ACAD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$34.3M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8.8M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.1M

ACADIA Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ACAD return on invested capital is -27.28%
  • What Is ACADIA Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -17.87%
  • What Is ACAD Return On Equity?
    ROE is a measure of profitability and is -27.28%

ACADIA Pharmaceuticals Earnings Date & Stock Price

ACADIA Pharmaceuticals Competitors

ACADIA Pharmaceuticals Dividend Yield

Data Unavailable

ACADIA Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 108.64%
Revenue: 22.79% 4.68%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 31.13
Upside from Last Price: 49.57%

Major Shareholders

  • How many ACAD shares are owned by institutional investors?
    242.7M ACAD shares are owned by institutional investors
  • How many ACAD shares are owned by insiders?
    836.8K ACAD shares are owned by insiders